-
Machine Learning (ML) Prediction of Parkinson’s Disease (PD) Risk and Nigral Neuron Density
-
Maintenance of physical activity (PA) mitigates worsening of patient-reported outcomes in Parkinson’s disease (PD) during the COVID-19 pandemic
-
Management of tremor secondary to MORC2 related neurodevelopmental disorder with deep brain stimulation
-
Mapping intrinsically photosensitive retinal ganglion cells (ipRGCs) dysfunction in patients with Parkinson disease using Chromatic pupilloperimetry
-
Mapping regional alpha-synuclein seeding capacity in Multiple System Atrophy
-
MAPT mutation frontotemporal dementia with parkinsonism: when previous results can skew the diagnosis
-
Markers of Parkinson-related impulsive-compulsive behaviors in the activity of single units in the subthalamic nucleus
-
Maximising UPDRS information while minimising assessment time
-
MDS Basic Scientists Survey demonstrates Potential for Crosspollination between Basic Scientists and MDS
-
MDS Translation Program for MDS-UPDRS, UDysRS, and MDS-NMS
-
MDSGene systematic review on dopa-responsive dystonia caused by mutations in GCH1, TH, SPR, PTS, or QDPR
-
Measures of Physical Activity in Parkinson’s Disease (MAPD)
-
Measuring progression of Parkinson’s disease cardinal signs in the Phase 2 SPARK study
-
Medically refractory Graves’ disease presenting as chorea and carbohydrate hyperphagia in a Kenyan adolescent
-
Medication effects and validity of home-based freezing tests in Parkinson’s disease
-
Metabolic activity and perfusion of basal ganglia in patients with hemichorea and carotid stenosis
-
Metabolic alterations in a Drosophila model of Parkinson’s disease
-
Metabolic patterns and neurodegeneration in isolated REM sleep behavior disorder
-
Metadata standards to support deployment of Digital Health Technologies in Clinical Trials in Parkinson’s Disease (PD)
-
Methods for addressing missing covariate data in left truncated samples with application to Parkinson’s disease research
-
Methylation status of SNCA gene in multiple system atrophy and Parkinson’s disease
-
MICROBIAL TRANSLOCATION IN PATIENTS WITH PARKINSON DISEASE AT THE UNIVERSITY TEACHING HOSPITAL, LUSAKA, ZAMBIA: A CASE CONTROL STUDY
-
MicroRNAs as a potential biomarker of Parkinson’s disease
-
Mild cognitive impairment does not predict development of dementia up to 15 years after subthalamic deep brain stimulation in Parkinson’s disease
-
Mild parkinsonian signs in older adults correlate with an impaired functional level – a cross-sectional general population study from the “Good Aging in Skåne” cohort
-
Minimum detectable change of an automated algorithm derived spiral analysis parameter
-
Mobile application for assessing the likelihood of developing depression in patients with Parkinson’s disease
-
Model Innovation in Parkinson’s disease drug development: linking Quantitative Systems Pharmacology to the patient voice
-
Modeling of the Placebo Response in Parkinson’s Disease
-
Molecular changes of a de novo missense variant in VPS16 in dystonia
-
Molecular investigation of apparently healthy heterozygous Parkin mutation carriers
-
MOLECULAR-GENETIC ASPECTS OF WILSON’S DISEASE IN UKRAINE
-
Monitoring electrophysiological parameters in PD patients enrolled for MRgFUS: l’Aquila-tor Vergata experience
-
Monogenic Hub of the Global Parkinson’s Genetics Program (GP2): The 500-genomes pilot project
-
Monogenic Portal of the Global Parkinson’s Genetics Program (GP2)
-
Mood is a Key Factor in Progression of Non-Motor Symptoms Burden in Parkinson´s disease.
-
Morbidity and mortality from neurodegenerative patients hospitalized with COVID-19 in the Chicagoland area
-
Mortality of people with Parkinson’s disease in a large population-based cohort study. Time trends and relationship to disease progression.
-
Motor and non-motor effects of mevidalen in Lewy Body Dementia as measured by the Movement Disorder Society’s Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)
-
Motor cerebro-cerebellar networks breakdown among different subtypes of Parkinson’s disease
-
Motor evaluation of Parkinson’s disease patients through video consultations in the Brazilian public health system – a real life feasibility study
-
Motor Function Test Protocol for Parkinsonian Triad in Rodent Model of Parkinson’s Disease
-
Motor skills of walking in Parkinson’s disease: towards a better understanding of the cognitive abilities implicated in F8WT.
-
Motor symptom lateralization influences cortico-striatal functional connectivity in Parkinson’s disease
-
Motor-cognitive interference during touchscreen manipulations in Parkinson’s disease
-
Movement Disorder Fellowships: Assessment and Recruitment Strategies to Meet Clinical Needs
-
MOVEMENT DISORDERS IN CHILDREN WITH ATP1A3 GENE MUTATIONS. A SERIES OF CHILEAN PATIENTS
-
Movement disorders in demyelination: A case series of ten patients
-
Movement Disorders in Subacute Sclerosing Panencephalitis Patients
-
Movement vigor is differentially encoded in motor cortex and globus pallidus in Parkinson disease
-
Movement-related dynamics of β-γ phase-amplitude coupling in repetitive movement tasks of Parkinson disease
-
MR guided high-intensity ultrasound thalamotomy in essential tremor and Parkinson´s disease: is there an ideal candidate?
-
MRgFUS Pallidothalamic Tractotomy for axial symptoms in Parkinson’s disease in 4 consecutive patients: single center experience
-
Multifractal spectrum width of pallidal activity correlates with dystonic severity
-
Multimodal Conversational AI for Remote Patient Monitoring and Analysis of Parkinson’s Disease
-
Multimodal, longitudinal investigation in Dopa-responsive dystonia
-
Mutation analysis of BSN gene in patients with multiple system atrophy
-
Mutations in GBA and LRRK2 are not associated with increased inflammatory markers
-
My hands are shaking : A Tunisian cohort study
-
Myoclonus, Tremor, and Ataxia After COVID-19 Infection
MDS Virtual Congress 2021
September 17-22, 2021. Virtual Congress. www.mdscongress.org